Liangyi Zhang

Company: Allogene Therapeutics

Job title: Director - Analytical Development

Seminars:

Identification and Control of Potential Critical Quality Attributes of mRNAs as Raw Material in CAR T Process 11:45 am

Developing a control strategy for gene editing tools for CAR-T processes Considering later effects of raw materials to present downstream failures Benchmarking required validation to identify QCAs for raw materialsRead more

day: Day 1 Track B- AM

Analytical Development Leaders Discussion: Appreciating the Heterogeneity of Cell Therapies to Develop a Fully Informed Analytical Package 8:40 am

Developing key considerations for a tailormade analytical suite Understanding product specificity to inform tool and technique selection Considering the impact of environmental factors on variability and how to control for this to develop a more robust analytical programRead more

day: Conference Day One

Highlighting Comparability Approaches to Improve Process Transfer 8:00 am

An interactive session exploring process to process comparability to streamline your workflow and increase confidence in your final product Key discussion points: Best practices for tackling analytical comparability How to tackle statistical approaches to comparability Key differences when thinking about comparability for autologous and allogeneic therapiesRead more

day: Workshop B